"estrogen receptor positive breast cancer" trang 11 - tải miễn phí từ tailieuXANH
COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer

COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer
10    56    0
Metabolic characterization of triple negative breast cancer

Metabolic characterization of triple negative breast cancer
12    58    0
Low levels of 3,3′-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol

Low levels of 3,3′-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol
10    52    0
NILCO biomarkers in breast cancer from Chinese patients

NILCO biomarkers in breast cancer from Chinese patients
12    57    0
Breast tumor specific mutation in GATA3 affects physiological mechanisms regulating transcription factor turnover

Breast tumor specific mutation in GATA3 affects physiological mechanisms regulating transcription factor turnover
14    60    0
Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response

Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response
16    61    0
Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites

Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites
10    52    0
Association between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer

Association between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer
13    49    0
Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: Results from a German population-based case-control study

Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: Results from a German population-based case-control study
9    52    0
Selective inhibition of RET mediated cell proliferation in vitro by the kinase inhibitor SPP86

Selective inhibition of RET mediated cell proliferation in vitro by the kinase inhibitor SPP86
13    48    0
Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers

Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers
16    107    0
Case report: Anti-hormonal therapy in the treatment of ductal carcinoma of the parotid gland

Case report: Anti-hormonal therapy in the treatment of ductal carcinoma of the parotid gland
4    89    0
ERβ1: Characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer

ERβ1: Characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer
16    68    0
COUP-TFI modifies CXCL12 and CXCR4 expression by activating EGF signaling and stimulates breast cancer cell migration

COUP-TFI modifies CXCL12 and CXCR4 expression by activating EGF signaling and stimulates breast cancer cell migration
13    45    0
Celecoxib increases miR-222 while deterring aromatase-expressing breast tumor growth in mice

Celecoxib increases miR-222 while deterring aromatase-expressing breast tumor growth in mice
13    58    0
ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: A systematic review and meta-analysis

ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: A systematic review and meta-analysis
11    89    0
Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer

Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer
9    60    0
Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/ VEGFR2 autocrine signaling

Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/ VEGFR2 autocrine signaling
15    79    0
Expression of activator protein-1 (AP-1) family members in breast cancer

Expression of activator protein-1 (AP-1) family members in breast cancer
10    58    0
Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies

Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies
11    61    1
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.